Align Technology [ALGN] vs ResMed [RMD] Detailed Stock Comparison

Align Technology Inc.

NASDAQ
Loading...

ResMed Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Align Technology Inc. wins in 10 metrics, ResMed Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Align Technology Inc. ResMed Inc. Better
P/E Ratio (TTM) 34.70 21.69 ResMed Inc.
Price-to-Book Ratio 3.46 5.06 Align Technology Inc.
Debt-to-Equity Ratio 2.83 13.41 Align Technology Inc.
PEG Ratio 0.96 1.50 Align Technology Inc.
EV/EBITDA 15.26 15.51 Align Technology Inc.
Profit Margin (TTM) 10.17% 27.53% ResMed Inc.
Operating Margin (TTM) 22.38% 35.16% ResMed Inc.
EBITDA Margin (TTM) 22.38% 35.16% ResMed Inc.
Return on Equity 10.39% 25.68% ResMed Inc.
Return on Assets (TTM) 6.94% 14.75% ResMed Inc.
Free Cash Flow (TTM) $490.78M $1.65B ResMed Inc.
Dividend Yield N/A 0.92% N/A
1-Year Return -3.31% -22.15% Align Technology Inc.
Price-to-Sales Ratio (TTM) 3.48 5.92 Align Technology Inc.
Enterprise Value $12.99B $31.41B ResMed Inc.
EV/Revenue Ratio 3.22 5.82 Align Technology Inc.
Gross Profit Margin (TTM) 65.26% 61.76% Align Technology Inc.
Revenue per Share (TTM) $56 $37 Align Technology Inc.
Earnings per Share (Diluted) $5.65 $10.12 ResMed Inc.
Beta (Stock Volatility) 1.81 0.93 ResMed Inc.
Short % of Float 6.94% 9.40% Align Technology Inc.

Align Technology Inc. vs ResMed Inc. Stock Performance Analysis

Loading Price Chart...

ALGN
RMD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Align Technology Inc.-2.99%1.92%-3.02%-11.81%10.44%6.83%
ResMed Inc.1.99%-12.09%-12.70%-28.97%-27.12%-25.32%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Align Technology Inc.-3.31%-42.07%-69.96%123.15%641.63%2,145.83%
ResMed Inc.-22.15%-13.63%-7.18%220.07%499.84%738.04%

Performance & Financial Health Analysis: Align Technology Inc. vs ResMed Inc.

MetricALGNRMD
Market Information
Market Cap i$13.66B$32.03B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i986,384955,842
90 Day Avg. Volume i1,182,9351,020,554
Last Close$161.71$186.46
52 Week Range$122.00 - $208.31$180.27 - $293.81
% from 52W High-22.37%-36.54%
All-Time High$737.45 (Sep 20, 2021)$301.34 (Sep 06, 2021)
% from All-Time High-78.07%-38.12%
Growth Metrics
Quarterly Revenue Growth0.05%0.11%
Quarterly Earnings Growth0.31%0.14%
Financial Health
Profit Margin (TTM) i0.10%0.28%
Operating Margin (TTM) i0.22%0.35%
Return on Equity (TTM) i0.10%0.26%
Debt to Equity (MRQ) i2.8313.41
Cash & Liquidity
Book Value per Share (MRQ)$56.74$43.39
Cash per Share (MRQ)$15.36$9.73
Operating Cash Flow (TTM) i$593.22M$1.91B
Levered Free Cash Flow (TTM) i$483.69M$1.42B
Dividends
Last 12-Month Dividend Yield iN/A0.92%
Last 12-Month Dividend iN/A$2.33

Valuation & Enterprise Metrics Analysis: Align Technology Inc. vs ResMed Inc.

MetricALGN (Apr 24, 2026)RMD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i34.7021.69
Forward P/E i15.9218.02
PEG Ratio i0.961.50
Price to Sales (TTM) i3.485.92
Price to Book (MRQ) i3.465.06
Market Capitalization
Market Capitalization i$13.66B$32.03B
Enterprise Value i$12.99B$31.41B
Enterprise Value Metrics
Enterprise to Revenue i3.225.82
Enterprise to EBITDA i15.2615.51
Risk & Other Metrics
Beta i1.810.93
Book Value per Share (MRQ) i$56.74$43.39

Financial Statements Comparison: Align Technology Inc. vs ResMed Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricALGN (2025)RMD (2025)
Revenue/Sales i4.03B5.15B
Cost of Goods Sold i1.32B2.09B
COGS % of Revenue i32.8%40.6%
Gross Profit i2.71B3.05B
Gross Margin i67.2%59.4%
Research & Development i369.91M331.28M
Operating Income (EBIT) i585.31M1.69B
Operating Margin i14.5%32.8%
EBITDA i862.30M1.93B
EBITDA Margin i21.4%37.4%
Pre-Tax Income i585.29M1.68B
Pre-Tax Income % of Revenue i14.5%32.6%
Income Tax i174.94M276.84M
Income Tax % of Revenue i4.3%5.4%
Net Income (Profit) i410.35M1.40B
Profit Margin i10.2%27.2%

Balance Sheet & Liquidity Metrics

MetricALGN (2025)RMD (2025)
Cash & Equivalents i1.09B1.21B
Total Current Assets i2.62B3.51B
Total Current Assets % of Revenue i64.8%68.1%
Total Current Liabilities i1.92B1.02B
Total Current Liabilities % of Revenue i47.6%19.8%
Long-Term Debt i82.51M811.41M
Long-Term Debt % of Revenue i2.0%15.8%
Total Shareholders Equity i4.05B5.97B
Retained Earnings i2.46B6.08B
Retained Earnings % of Revenue i61.1%118.2%
Property, Plant & Equipment i956.80M288.62M

Cash Flow Statement Comparison

MetricALGN (2025)RMD (2025)
Operating Cash Flow i698.64M1.57B
Operating Cash Flow % of Revenue i17.3%30.5%
Capital Expenditures i-102.45M-89.87M
Free Cash Flow i490.78M1.65B
FCF Margin i12.2%32.1%
Debt Repayment iN/A-40.00M
Common Stock Repurchase i-465.94M-300.03M

Short Interest & Institutional Ownership Analysis

MetricALGNRMD
Shares Short i4.35M11.89M
Short Ratio i3.3411.24
Short % of Float i6.94%9.40%
Shares Outstanding i71.36M145.66M
Float Shares i66.73M144.79M
% Held by Insiders i6.82%0.50%
% Held by Institutions i97.35%68.82%
% Held by Public i-4.17%30.68%

Dividend Analysis & Yield Comparison: Align Technology Inc. vs ResMed Inc.

MetricALGNRMD
Last 12-Month Dividend iN/A$2.33
Last 12-Month Dividend Yield iN/A0.92%
3-Year Avg Annual Dividend iN/A$2.09
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$6.28
Ex-Dividend DateN/AFeb 12, 2026